NORMA HUGHES: Open Payments
NPI 1063879054 · SAMSON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 18 payments from 6 companies in 2025. Trend: 2023 $271 · 2024 $384 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $135 |
| Novo Nordisk Inc | 5 | $89 |
| Lilly USA, LLC | 5 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| ABBVIE INC. | 2 | $41 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: FARXIGA, MOUNJARO, CAPLYTA, VRAYLAR, Ozempic, Wegovy, Rybelsus, ZEPBOUND.
Industry payments across AL — which companies pay providers there.
